FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Maxine Stitzer

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Activities & Behaviors

Procedures

Organizations

Substance Abuse Treatment Centers

Co-author Network

Publications

TOP 3
Hildi J Hagedorn; Ann Bangerter; Siamak Noorbaloochi; Alisha Baines Simon; Cheryl B Stetler; Maxine L Stitzer; Daniel Kivlahan
Rewarding early abstinence in Veterans Health Administration addiction clinics.
Erin A McClure; Shauna P Acquavita; Emily Harding; Maxine L Stitzer
Utilization of communication technology by patients enrolled in substance abuse treatment.
Robert P Schwartz; Ned Snead; Maxine L Stitzer; Theresa M Winhusen; Anika A.H. Alvanzo; Lillian Donnard; Daniel J Feaster; Philip Todd Korthuis; Lisa R Metsch
HIV rapid testing in drug treatment: comparison across treatment modalities.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Maxine Stitzer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Hildi J Hagedorn; Ann Bangerter; Siamak Noorbaloochi; Alisha Baines Simon; Cheryl B Stetler; Maxine L Stitzer; Daniel Kivlahan
Rewarding early abstinence in Veterans Health Administration addiction clinics.
Journal of substance abuse treatment 2013;45(1):109-17.
2013: Erin A McClure; Shauna P Acquavita; Emily Harding; Maxine L Stitzer
Utilization of communication technology by patients enrolled in substance abuse treatment.
Drug and alcohol dependence 2013;129(1-2):145-50.
2013: Robert P Schwartz; Ned Snead; Maxine L Stitzer; Theresa M Winhusen; Anika A.H. Alvanzo; Lillian Donnard; Daniel J Feaster; Philip Todd Korthuis; Lisa R Metsch
HIV rapid testing in drug treatment: comparison across treatment modalities.
Journal of substance abuse treatment 2013;44(4):369-74.
2013: Maxine L Stitzer
Dual dilemma-should naltrexone be used in the treatment of opioid-dependent pregnant women?
Addiction (Abingdon, England) 2013;108(2):249-50.
2013: Ryan Vandrey; Marilyn A Huestis; Miriam Z Mintzer; Jeannie A Murray; Maxine L Stitzer; Dayong Lee
The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users.
Drug and alcohol dependence 2013;128(1-2):64-70.
2013: Erin A McClure; Matthew W Johnson; Ryan Vandrey; Maxine L Stitzer
Effects of varenicline on abstinence and smoking reward following a programmed lapse.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 2013;15(1):139-48.
2012: Theresa M Winhusen; George Woody; Steven Sparenborg; Maxine L Stitzer; Paul Vanveldhuisen; Bryon Adinoff; Kathleen T Brady; Greg Brigham; Frankie Kropp; Robert Lindblad; David Liu; Gaurav Sharma; Eugene C Somoza
Evaluation of buspirone for relapse-prevention in adults with cocaine dependence: an efficacy trial conducted in the real world.
Contemporary clinical trials 2012;33(5):993-1002.
2012: Kimberly C Kirby; Nancy M Petry; Karen Reese; John M Roll; Michael E Saladin; Gina R Sillo; Patricia Quinn Stabile; Carolyn M Carpenedo; Allan J Cohen; Karen L Dugosh; John Hamilton; Maxine L Stitzer; Robert C Sterling
Is exposure to an effective contingency management intervention associated with more positive provider beliefs?
Journal of substance abuse treatment 2012;42(4):356-65.
2012: Christine Sheffer; Maxine L Stitzer; Richard Yi; Lawrence Carter; Darren Christensen; Lisa Jackson; Bryan Jones; Reid Landes; James MacKillop; John McGeary; Warren Bickel
Delay discounting, locus of control, and cognitive impulsiveness independently predict tobacco dependence treatment outcomes in a highly dependent, lower socioeconomic group of smokers.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2012;21(3):221-32.
2012: L TUTEN; Anthony Louis DeFulio; Hendrée E Jones; Maxine L Stitzer
Abstinence-contingent recovery housing and reinforcement-based treatment following opioid detoxification.
Addiction (Abingdon, England) 2012;107(5):973-82.
2012: Danielle S Rudes; Maxine L Stitzer; Faye S Taxman; Peter F Luongo; Amy Murphy; Shannon Portillo; Anne Rhodes; Peter D Friedmann
Adding positive reinforcement in justice settings: acceptability and feasibility.
Journal of substance abuse treatment 2012;42(3):260-70.
2012: Christine E Sheffer; Maxine L Stitzer; S Laney Brackman; Reid Landes; Tiffany Munn; Page Moore
Socioeconomic disparities in community-based treatment of tobacco dependence.
American journal of public health 2012;102(3):e8-16.
2012: Aimee N C Campbell; Kathleen M Carroll; Rita Chapdelaine; Sara Clingerman; Genie L Bailey; Autumn Froias; Udi E Ghitza; Bruce Goldman; Abigail Matthews; Erin McClure; Gloria M Miele; Edward V Nunes; Livangelie Perez; Daniel Polsky; Maxine L Stitzer; Eva Turrigiano; Paul Vanveldhuisen; Theresa M Winhusen; A Rebecca Crowell
Design and methodological considerations of an effectiveness trial of a computer-assisted intervention: an example from the NIDA Clinical Trials Network.
Contemporary clinical trials 2012;33(2):386-95.
2012: Carla J Rash; John Roll; Kimberly C Kirby; Steve Martino; Nancy M Petry; Maxine L Stitzer
Identifying provider beliefs related to contingency management adoption using the contingency management beliefs questionnaire.
Drug and alcohol dependence 2012;121(3):205-12.
2012: Erin A McClure; Maxine L Stitzer; Ryan Vandrey
Characterizing smoking topography of cannabis in heavy users.
Psychopharmacology 2012;220(2):309-18.
2012: Theresa Winhusen; Robert Lindblad; Bryon Adinoff; Frankie Kropp; George Woody; Cindy Green; Udi Ghitza; Gregory Brigham; Maxine L Stitzer; Gaurav Sharma; Eugene Somoza
Design considerations for a study to evaluate the impact of smoking cessation treatment on stimulant use outcomes in stimulant-dependent individuals.
Contemporary clinical trials 2012;33(1):197-205.
2012: Dace S. Svikis; Tim Allen; Traci Rieckmann; Maxine L Stitzer; Conrad Jung Liang Wong; Allison Sepulveda; Diane Pallas; Scott Provost; Lauretta Safford; Lori Keyser-Marcus; Carol Luna-Anderson; Michael A DeBernardi; Michael Levy; Jennifer Potter; Royce R Sampson; William Jaffee; Karen Reese; Ned Snead; Peter Loeb; Bruce Dillard; Therese Killeen; Sudie E Back; Alyssa Forcehimes; Ken Kolodner; Harold I Perl; Judith Cohen; Joan Zweben
Randomized multi-site trial of the Job Seekers' Workshop in patients with substance use disorders.
Drug and alcohol dependence 2012;120(1-3):55-64.
2011: Karen L Cropsey; Galen J Hale; Karen S Ingersoll; M Aminul Islam; Dorothy O Jackson; Peter S Lane; C Brendan Clark; Maxine L Stitzer
Results of a pilot randomized controlled trial of buprenorphine for opioid dependent women in the criminal justice system.
Drug and alcohol dependence 2011;119(3):172-8.
2011: GEETHA SUBRAMANIAM; Madhukar Trivedi; Diane Warden; Roger Weiss; Bryon Adinoff; Marc J Fishman; Abu Minhajuddin; Sabrina A Poole; Jennifer Potter; Maxine L Stitzer; George E Woody
Predictors of abstinence: National Institute of Drug Abuse multisite buprenorphine/naloxone treatment trial in opioid-dependent youth.
Journal of the American Academy of Child and Adolescent Psychiatry 2011;50(11):1120-8.
2011: Yih-Ing Hser; David Huang; Haifeng Jiang; Jianhua Li; Chinyi Peng; John Roll; Maxine L Stitzer; Fei Wu; Bo Zhang; Congbin Zhang; Ruimin Zhang; Yen-Jung Chang; Jiang Du; Elizabeth Evans; Min Zhao
Effects of a randomized contingency management intervention on opiate abstinence and retention in methadone maintenance treatment in China.
Addiction (Abingdon, England) 2011;106(10):1801-9.
2011: Kathleen Carroll; Ron Jackson; Steve Martino; Nancy M Petry; Maxine L Stitzer; Samuel A Ball; Elizabeth A Wells; Roger D Weiss
Ten take home lessons from the first 10 years of the CTN and 10 recommendations for the future.
The American journal of drug and alcohol abuse 2011;37(5):275-82.
2011: Ryan Vandrey; Maxine L Stitzer; Shauna P Acquavita; Patricia Quinn-Stabile
Pay-for-performance in a community substance abuse clinic.
Journal of substance abuse treatment 2011;41(2):193-200.
2011: Karen L Cropsey; Dorothy O Jackson; Galen J Hale; Matthew J Carpenter; Maxine L Stitzer
Impact of self-initiated pre-quit smoking reduction on cessation rates: results of a clinical trial of smoking cessation among female prisoners.
Addictive behaviors 2011;36(1-2):73-8.
2010: Karen L Cropsey; Leslie A McClure; Dorothy O Jackson; Gabrielle C Villalobos; Michael F Weaver; Maxine L Stitzer
The impact of quitting smoking on weight among women prisoners participating in a smoking cessation intervention.
American journal of public health 2010;100(8):1442-8.
2010: Christine E Sheffer; Maxine L Stitzer; Thomas Brandon; Zoran Bursac
Effectiveness of adding relapse prevention materials to telephone counseling.
Journal of substance abuse treatment 2010;39(1):71-7.
2010: Kenneth A Perkins; Caryn Lerman; Carolyn Fonte; M Mercincavage; Maxine L Stitzer; K N R Chengappa; A Jain
Cross-validation of a new procedure for early screening of smoking cessation medications in humans.
Clinical pharmacology and therapeutics 2010;88(1):109-14.
2010: Edward V Nunes; Samuel Ball; Robert Booth; Gregory Brigham; Donald A Calsyn; Kathleen Carroll; Daniel J Feaster; Denise Hien; Robert L Hubbard; Walter Ling; Nancy M Petry; John Rotrosen; Jeffrey Selzer; Maxine L Stitzer; Susan Tross; Paul Wakim; Theresa Winhusen; George Woody
Multisite effectiveness trials of treatments for substance abuse and co-occurring problems: have we chosen the best designs?
Journal of substance abuse treatment 2010;38 Suppl 1():S97-112.
2010: LI-TZY WU; Jeng-Jong Pan; Dan G Blazer; Betty Tai; Maxine L Stitzer; George E Woody
Using a latent variable approach to inform gender and racial/ethnic differences in cocaine dependence: a National Drug Abuse Treatment Clinical Trials Network study.
Journal of substance abuse treatment 2010;38 Suppl 1():S70-9.
2010: Maxine L Stitzer; Nancy M Petry; Jessica M Peirce
Motivational incentives research in the National Drug Abuse Treatment Clinical Trials Network.
Journal of substance abuse treatment 2010;38 Suppl 1():S61-9.
2010: GEETHA SUBRAMANIAM; Melissa L Ives; Maxine L Stitzer; Michael L Dennis
The added risk of opioid problem use among treatment-seeking youth with marijuana and/or alcohol problem use.
Addiction (Abingdon, England) 2010;105(4):686-98.
2010: Dorothy Octavia Jackson; Karen L Cropsey; Michael F Weaver; Gabriella C Villalobos; Gloria Eldridge; Maxine L Stitzer
Factors related to injection drug use among female prisoners.
Substance use & misuse 2010;45(3):368-83.
2010: Maxine L Stitzer; Tiffany Polk; Sarah Bowles; Thomas Kosten
Drug users' adherence to a 6-month vaccination protocol: effects of motivational incentives.
Drug and alcohol dependence 2010;107(1):76-9.
2009: Lawrence P Carter; Maxine L Stitzer; Jack E Henningfield; Rich J O'Connor; K Michael Cummings; Dorothy K Hatsukami
Abuse liability assessment of tobacco products including potential reduced exposure products.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(12):3241-62.
2009: Eldon T Mueller; Reid D Landes; Benjamin P Kowal; Richard Yi; Maxine L Stitzer; Cody A Burnett; Warren K Bickel
Delay of smoking gratification as a laboratory model of relapse: effects of incentives for not smoking, and relationship with measures of executive function.
Behavioural pharmacology 2009;20(5-6):461-73.
2009: Mohit P Chopra; Reid D Landes; Kirstin M Gatchalian; Lisa C Jackson; August R Buchhalter; Maxine L Stitzer; Lisa A Marsch; Warren K Bickel
Buprenorphine medication versus voucher contingencies in promoting abstinence from opioids and cocaine.
Experimental and clinical psychopharmacology 2009;17(4):226-36.
2009: LI-TZY WU; Jeng-Jong Pan; Dan G Blazer; Betty Tai; Robert K Brooner; Maxine L Stitzer; Ashwin A Patkar; Jack D Blaine
The construct and measurement equivalence of cocaine and opioid dependences: a National Drug Abuse Treatment Clinical Trials Network (CTN) study.
Drug and alcohol dependence 2009;103(3):114-23.
2009: Karen L Cropsey; Michael F Weaver; Gloria D Eldridge; Gabriela C Villalobos; Al M Best; Maxine L Stitzer
Differential success rates in racial groups: results of a clinical trial of smoking cessation among female prisoners.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 2009;11(6):690-7.
2009: Christine E Sheffer; Maxine L Stitzer; Thomas J Payne; Bradford W Applegate; David Bourne; J Gary Wheeler
Treatment for tobacco dependence for rural, lower-income smokers: outcomes, predictors, and measurement considerations.
American journal of health promotion : AJHP 2009;23(5):328-38.
2009: LI-TZY WU; Jeng-Jong Pan; Dan G Blazer; Betty Tai; Maxine L Stitzer; Robert K Brooner; George E Woody; Ashwin A Patkar; Jack D Blaine
An item response theory modeling of alcohol and marijuana dependences: a National Drug Abuse Treatment Clinical Trials Network study.
Journal of studies on alcohol and drugs 2009;70(3):414-25.
2009: LI-TZY WU; Dan G Blazer; Ashwin A Patkar; Maxine L Stitzer; Paul G Wakim; Robert K Brooner
Heterogeneity of stimulant dependence: a national drug abuse treatment clinical trials network study.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2009;18(3):206-18.
2009: GEETHA SUBRAMANIAM; Maxine L Stitzer
Clinical characteristics of treatment-seeking prescription opioid vs. heroin-using adolescents with opioid use disorder.
Drug and alcohol dependence 2009;101(1-2):13-9.
2009: Christine Sheffer; Maxine L Stitzer; J Gary Wheeler
Smoke-free medical facility campus legislation: support, resistance, difficulties and cost.
International journal of environmental research and public health 2009;6(1):246-58.
2009: Jessica M Peirce; Nancy M Petry; John M Roll; Ken Kolodner; Joe Krasnansky; Patricia Q Stabile; Chanda Brown; Maxine L Stitzer
Correlates of stimulant treatment outcome across treatment modalities.
The American journal of drug and alcohol abuse 2009;35(1):48-53.
2009: GEETHA SUBRAMANIAM; Maxine L Stitzer; George Woody; Marc J Fishman; Ken Kolodner
Clinical characteristics of treatment-seeking adolescents with opioid versus cannabis/alcohol use disorders.
Drug and alcohol dependence 2009;99(1-3):141-9.
2008: Randall E Rogers; Stephen T Higgins; Kenneth Silverman; Colleen Thomas; Gary J Badger; George E Bigelow; Maxine L Stitzer
Abstinence-contingent reinforcement and engagement in non-drug-related activities among illicit drug abusers.
Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors 2008;22(4):544-50.
2008: Nancy M Petry; John M Roll; Bruce J Rounsaville; Samuel A Ball; Maxine L Stitzer; Jessica M Peirce; Jack Blaine; Kimberly Kirby; Dennis McCarty; Kathleen Carroll
Serious adverse events in randomized psychosocial treatment studies: safety or arbitrary edicts?
Journal of consulting and clinical psychology 2008;76(6):1076-82.
2008: Karen L Cropsey; Gloria Eldridge; Michael Weaver; Gabriela Villalobos; Maxine L Stitzer; Al Best
Smoking cessation intervention for female prisoners: addressing an urgent public health need.
American journal of public health 2008;98(10):1894-901.
2008: Kenneth A Perkins; Caryn Lerman; Maxine L Stitzer; Carolyn Fonte; J L Briski; J A Scott; K N R Chengappa
Development of procedures for early screening of smoking cessation medications in humans.
Clinical pharmacology and therapeutics 2008;84(2):216-21.
2008: LI-TZY WU; Dan G Blazer; Maxine L Stitzer; Ashwin A Patkar; Jack Blaine
Infrequent illicit methadone use among stimulant-using patients in methadone maintenance treatment programs: a national drug abuse treatment clinical trials network study.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2008;17(4):304-11.
2008: Maxine L Stitzer; Ryan Vandrey
Contingency management: utility in the treatment of drug abuse disorders.
Clinical pharmacology and therapeutics 2008;83(4):644-7.
2008: Maxine L Stitzer
Brief interventions for tobacco cessation.
Addiction (Abingdon, England) 2008;103(2):305-6; discussion 309.
2008: Erin L Winstanley; Donald M Steinwachs; Margaret E Ensminger; Carl A Latkin; Maxine L Stitzer; Yngvild Olsen
The association of self-reported neighborhood disorganization and social capital with adolescent alcohol and drug use, dependence, and access to treatment.
Drug and alcohol dependence 2008;92(1-3):173-82.
2007: Maxine L Stitzer; Nancy M Petry; Jessica M Peirce; Kimberly Kirby; Therese K Killeen; John M Roll; John Hamilton; Patricia Q Stabile; Robert Sterling; Chanda Brown; Ken Kolodner; Rui Li
Effectiveness of abstinence-based incentives: interaction with intake stimulant test results.
Journal of consulting and clinical psychology 2007;75(5):805-11.
2007: Maxine L Stitzer; Jessica M Peirce; Nancy M Petry; Kimberly Kirby; John M Roll; Joseph Krasnansky; Allan Cohen; Jack Blaine; Ryan Vandrey; Ken Kolodner; Rui Li
Abstinence-based incentives in methadone maintenance: interaction with intake stimulant test results.
Experimental and clinical psychopharmacology 2007;15(4):344-50.
2007: Ryan Vandrey; George E Bigelow; Maxine L Stitzer
Contingency management in cocaine abusers: a dose-effect comparison of goods-based versus cash-based incentives.
Experimental and clinical psychopharmacology 2007;15(4):338-43.
2007: GEETHA SUBRAMANIAM; Maxine L Stitzer; Philip Clemmey; Ken Kolodner; Marc J Fishman
Baseline depressive symptoms predict poor substance use outcome following adolescent residential treatment.
Journal of the American Academy of Child and Adolescent Psychiatry 2007;46(8):1062-9.
2007: Eric C Donny; Elisabeth J Houtsmuller; Maxine L Stitzer
Smoking in the absence of nicotine: behavioral, subjective and physiological effects over 11 days.
Addiction (Abingdon, England) 2007;102(2):324-34.
2007: Dace S. Svikis; Kenneth Silverman; Nancy A Haug; Maxine L Stitzer; Lori Keyser-Marcus
Behavioral strategies to improve treatment participation and retention by pregnant drug-dependent women.
Substance use & misuse 2007;42(10):1527-35.
2007: L TUTEN; Hendrée E Jones; Elizabeth W Lertch; Maxine L Stitzer
Aftercare plans of inpatients undergoing detoxification.
The American journal of drug and alcohol abuse 2007;33(4):547-55.
2007: Therese K Killeen; Rickey Carter; Marc L Copersino; Nancy M Petry; Maxine L Stitzer
Effectiveness of motivational incentives in stimulant abusing outpatients with different treatment histories.
The American journal of drug and alcohol abuse 2007;33(1):129-37.
2006: Laura M Juliano; Elisabeth J Houtsmuller; Maxine L Stitzer
A preliminary investigation of rapid smoking as a lapse-responsive treatment for tobacco dependence.
Experimental and clinical psychopharmacology 2006;14(4):429-38.
2006: John M Roll; Nancy M Petry; Maxine L Stitzer; Mary-Lynn Brecht; Jessica M Peirce; Michael J McCann; Jack Blaine; Marilyn MacDonald; Joan DiMaria; Leroy Lucero; Scott Kellogg
Contingency management for the treatment of methamphetamine use disorders.
The American journal of psychiatry 2006;163(11):1993-9.
2006: Maxine L Stitzer
Contingency management and the addictions.
Addiction (Abingdon, England) 2006;101(11):1536-7.
2006: Karen L Cropsey; Gloria D Eldridge; Michael F Weaver; Gabriela C Villalobos; Maxine L Stitzer
Expired carbon monoxide levels in self-reported smokers and nonsmokers in prison.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 2006;8(5):653-9.
2006: Nancy M Petry; Ken Kolodner; Rui Li; Jessica M Peirce; John M Roll; Maxine L Stitzer; John A Hamilton
Prize-based contingency management does not increase gambling.
Drug and alcohol dependence 2006;83(3):269-73.
2006: Kenneth A Perkins; Maxine L Stitzer; Caryn Lerman
Medication screening for smoking cessation: a proposal for new methodologies.
Psychopharmacology 2006;184(3-4):628-36.
2006: Laura M Juliano; Eric C Donny; Elisabeth J Houtsmuller; Maxine L Stitzer
Experimental evidence for a causal relationship between smoking lapse and relapse.
Journal of abnormal psychology 2006;115(1):166-73.
2006: Jessica M Peirce; Nancy M Petry; Maxine L Stitzer; Jack Blaine; Scott Kellogg; Frank Satterfield; Marion Schwartz; Joe Krasnansky; Eileen Pencer; Lolita Silva-Vazquez; Kimberly Kirby; Charlotte Royer-Malvestuto; John M Roll; Allan Cohen; Marc L Copersino; Ken Kolodner; Rui Li
Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
Archives of general psychiatry 2006;63(2):201-8.
2006: Maxine L Stitzer; Nancy M Petry
Contingency management for treatment of substance abuse.
Annual review of clinical psychology 2006;2():411-34.
2005: Stacey C Sigmon; Maxine L Stitzer
Use of a low-cost incentive intervention to improve counseling attendance among methadone-maintained patients.
Journal of substance abuse treatment 2005;29(4):253-8.
2005: Nancy M Petry; Jessica M Peirce; Maxine L Stitzer; Jack Blaine; John M Roll; Allan Cohen; Jeanne Obert; Therese K Killeen; Michael E Saladin; Mark Cowell; Kimberly Kirby; Robert Sterling; Charlotte Royer-Malvestuto; John Hamilton; Robert E Booth; Marilyn Macdonald; Marc Liebert; Linda Rader; Raynetta Burns; Joan DiMaria; Marc L Copersino; Patricia Quinn Stabile; Ken Kolodner; Rui Li
Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
Archives of general psychiatry 2005;62(10):1148-56.
2005: Eric C Donny; Susan M Brasser; George E Bigelow; Maxine L Stitzer; Sharon L Walsh
Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers.
Addiction (Abingdon, England) 2005;100(10):1496-509.
2005: Jack E Henningfield; Reginald V Fant; August R Buchhalter; Maxine L Stitzer
Pharmacotherapy for nicotine dependence.
CA: a cancer journal for clinicians 2005;55(5):281-99; quiz 322-3, 325.
2005: Chris Correia; Stacey C Sigmon; Kenneth Silverman; George E Bigelow; Maxine L Stitzer
A comparison of voucher-delivery schedules for the initiation of cocaine abstinence.
Experimental and clinical psychopharmacology 2005;13(3):253-8.
2005: Maxine L Stitzer
Classic texts revisited. Re: Similarities in Animal and Human Drug-Taking Behavior by Roland R. Griffiths, George E. Bigelow, Jack E. Henningfield, in: Advances in Substance Abuse, Volume 1, JAI Press Inc., 1980, pp. 190.
Addiction (Abingdon, England) 2005;100(8):1196-7.
2005: Hendrée E Jones; Conrad Jung Liang Wong; L TUTEN; Maxine L Stitzer
Reinforcement-based therapy: 12-month evaluation of an outpatient drug-free treatment for heroin abusers.
Drug and alcohol dependence 2005;79(2):119-28.
2005: Miriam Z Mintzer; Marc L Copersino; Maxine L Stitzer
Opioid abuse and cognitive performance.
Drug and alcohol dependence 2005;78(2):225-30.
2005: James Rosado; Stacey C Sigmon; Hendrée E Jones; Maxine L Stitzer
Cash value of voucher reinforcers in pregnant drug-dependent women.
Experimental and clinical psychopharmacology 2005;13(1):41-7.
2005: Scott H Kellogg; Marylee Burns; Peter Coleman; Maxine L Stitzer; Joyce B Wale; Mary Jeanne Kreek
Something of value: the introduction of contingency management interventions into the New York City Health and Hospital Addiction Treatment Service.
Journal of substance abuse treatment 2005;28(1):57-65.
2004: Stacey C Sigmon; Chris Correia; Maxine L Stitzer
Cocaine abstinence during methadone maintenance: effects of repeated brief exposure to voucher-based reinforcement.
Experimental and clinical psychopharmacology 2004;12(4):269-75.
2004: Elizabeth C Katz; Mary Ann Chutuape; Hendrée E Jones; Donald R Jasinski; Michael Fingerhood; Maxine L Stitzer
Abstinence incentive effects in a short-term outpatient detoxification program.
Experimental and clinical psychopharmacology 2004;12(4):262-8.
2004: Marc L Copersino; Mark R Serper; Nehal P Vadhan; Brett R Goldberg; Danielle Richarme; James C-Y Chou; Maxine L Stitzer; Robert Cancro
Cocaine craving and attentional bias in cocaine-dependent schizophrenic patients.
Psychiatry research 2004;128(3):209-18.
2004: Kenneth Silverman; Elias Robles; Timothy Mudric; George E Bigelow; Maxine L Stitzer
A randomized trial of long-term reinforcement of cocaine abstinence in methadone-maintained patients who inject drugs.
Journal of consulting and clinical psychology 2004;72(5):839-54.
2004: Wendy B Kissin; Dace S. Svikis; Paula Moylan; Nancy A Haug; Maxine L Stitzer
Identifying pregnant women at risk for early attrition from substance abuse treatment.
Journal of substance abuse treatment 2004;27(1):31-8.
2004: GEETHA SUBRAMANIAM; Lindy L Lewis; Maxine L Stitzer; Marc J Fishman
Depressive symptoms in adolescents during residential treatment for substance use disorders.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2004;13(3):256-67.
2004: Zulema Cumberbatch; Marc L Copersino; Maxine L Stitzer; Hendrée E Jones
Comparative drug use and psychosocial profiles of opioid dependents applying for medication versus medication-free treatment.
The American journal of drug and alcohol abuse 2004;30(2):237-49.
2003: Chris Correia; Jesse Dallery; Elizabeth C Katz; Kenneth Silverman; George E Bigelow; Maxine L Stitzer
Single- versus dual-drug target: effects in a brief abstinence incentive procedure.
Experimental and clinical psychopharmacology 2003;11(4):302-8.
2003: Elisabeth J Houtsmuller; Jack E Henningfield; Maxine L Stitzer
Subjective effects of the nicotine lozenge: assessment of abuse liability.
Psychopharmacology 2003;167(1):20-7.
2003: Jesse Dallery; Elisabeth J Houtsmuller; Wallace B Pickworth; Maxine L Stitzer
Effects of cigarette nicotine content and smoking pace on subsequent craving and smoking.
Psychopharmacology 2003;165(2):172-80.
2002: Elisabeth J Houtsmuller; James A Thornton; Maxine L Stitzer
Effects of selegiline (L-deprenyl) during smoking and short-term abstinence.
Psychopharmacology 2002;163(2):213-20.
2002: Kenneth Silverman; Dace S. Svikis; Conrad Jung Liang Wong; Jacqueline Hampton; Maxine L Stitzer; George E Bigelow
A reinforcement-based therapeutic workplace for the treatment of drug abuse: three-year abstinence outcomes.
Experimental and clinical psychopharmacology 2002;10(3):228-40.
2002: Elisabeth J Houtsmuller; Reginald V Fant; Thomas Eissenberg; Jack E Henningfield; Maxine L Stitzer
Flavor improvement does not increase abuse liability of nicotine chewing gum.
Pharmacology, biochemistry, and behavior 2002;72(3):559-68.
2002: Miriam Z Mintzer; Maxine L Stitzer
Cognitive impairment in methadone maintenance patients.
Drug and alcohol dependence 2002;67(1):41-51.
2002: Elizabeth C Katz; Mary Ann Chutuape; Hendrée E Jones; Maxine L Stitzer
Voucher reinforcement for heroin and cocaine abstinence in an outpatient drug-free program.
Experimental and clinical psychopharmacology 2002;10(2):136-43.
2002: Eric C Donny; Sharon L Walsh; George E Bigelow; Thomas Eissenberg; Maxine L Stitzer
High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans.
Psychopharmacology 2002;161(2):202-12.
2002: Elizabeth C Katz; Elias Robles-Sotelo; Chris Correia; Kenneth Silverman; Maxine L Stitzer; George E Bigelow
The brief abstinence test: effects of continued incentive availability on cocaine abstinence.
Experimental and clinical psychopharmacology 2002;10(1):10-7.
2002: Elias Robles; Maxine L Stitzer; Eric C Strain; George E Bigelow; Kenneth Silverman
Voucher-based reinforcement of opiate abstinence during methadone detoxification.
Drug and alcohol dependence 2002;65(2):179-89.
2001: Nancy A Haug; Maxine L Stitzer; Dace S. Svikis
Smoking during pregnancy and intention to quit: a profile of methadone-maintained women.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 2001;3(4):333-9.
2001: Giao Q Tran; D A Bux; Nancy A Haug; Maxine L Stitzer; Dace S. Svikis
MMPI-2 typology of pregnant drug-dependent women in treatment.
Psychological assessment 2001;13(3):336-46.
2001: Jesse Dallery; Kenneth Silverman; Mary Ann Chutuape; George E Bigelow; Maxine L Stitzer
Voucher-based reinforcement of opiate plus cocaine abstinence in treatment-resistant methadone patients: effects of reinforcer magnitude.
Experimental and clinical psychopharmacology 2001;9(3):317-25.
2001: Mary Ann Chutuape; Kenneth Silverman; Maxine L Stitzer
Effects of urine testing frequency on outcome in a methadone take-home contingency program.
Drug and alcohol dependence 2001;62(1):69-76.
2001: Kenneth Silverman; Dace S. Svikis; Elias Robles; Maxine L Stitzer; George E Bigelow
A reinforcement-based therapeutic workplace for the treatment of drug abuse: six-month abstinence outcomes.
Experimental and clinical psychopharmacology 2001;9(1):14-23.
2001: Mary Ann Chutuape; Donald R Jasinski; Michael Fingerhood; Maxine L Stitzer
One-, three-, and six-month outcomes after brief inpatient opioid detoxification.
The American journal of drug and alcohol abuse 2001;27(1):19-44.
2001: Hendrée E Jones; Nancy A Haug; Kenneth Silverman; Maxine L Stitzer; Dace S. Svikis
The effectiveness of incentives in enhancing treatment attendance and drug abstinence in methadone-maintained pregnant women.
Drug and alcohol dependence 2001;61(3):297-306.
2001: A B Becker; Eric C Strain; George E Bigelow; Maxine L Stitzer; Rolley E. Johnson
Gradual dose taper following chronic buprenorphine.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2001;10(2):111-21.
2001: Elizabeth C Katz; K Gruber; Mary Ann Chutuape; Maxine L Stitzer
Reinforcement-based outpatient treatment for opiate and cocaine abusers.
Journal of substance abuse treatment 2001;20(1):93-8.
2001: Mary Ann Chutuape; Elizabeth C Katz; Maxine L Stitzer
Methods for enhancing transition of substance dependent patients from inpatient to outpatient treatment.
Drug and alcohol dependence 2001;61(2):137-43.
2000: Rolley E. Johnson; Mary Ann Chutuape; Eric C Strain; Sharon L Walsh; Maxine L Stitzer; George E Bigelow
A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence.
The New England journal of medicine 2000;343(18):1290-7.
2000: Mark K Greenwald; Maxine L Stitzer
Antinociceptive, subjective and behavioral effects of smoked marijuana in humans.
Drug and alcohol dependence 2000;59(3):261-75.
2000: Hendrée E Jones; Nancy A Haug; Maxine L Stitzer; Dace S. Svikis
Improving treatment outcomes for pregnant drug-dependent women using low-magnitude voucher incentives.
Addictive behaviors 2000;25(2):263-7.
2000: Elias Robles; Kenneth Silverman; Kenzie L. Preston; Edward J Cone; E Katz; George E Bigelow; Maxine L Stitzer
The brief abstinence test: voucher-based reinforcement of cocaine abstinence.
Drug and alcohol dependence 2000;58(1-2):205-12.
2000: K Gruber; Mary Ann Chutuape; Maxine L Stitzer
Reinforcement-based intensive outpatient treatment for inner city opiate abusers: a short-term evaluation.
Drug and alcohol dependence 2000;57(3):211-23.
1999: Kenneth Silverman; Mary Ann Chutuape; George E Bigelow; Maxine L Stitzer
Voucher-based reinforcement of cocaine abstinence in treatment-resistant methadone patients: effects of reinforcement magnitude.
Psychopharmacology 1999;146(2):128-38.
1999: S H Armenian; Mary Ann Chutuape; Maxine L Stitzer
Predictors of discharges against medical advice from a short-term hospital detoxification unit.
Drug and alcohol dependence 1999;56(1):1-8.
1999: Kory J Schuh; Sharon L Walsh; Maxine L Stitzer
Onset, magnitude and duration of opioid blockade produced by buprenorphine and naltrexone in humans.
Psychopharmacology 1999;145(2):162-74.
1999: Thomas Eissenberg; Maxine L Stitzer; George E Bigelow; August R Buchhalter; Sharon L Walsh
Relative potency of levo-alpha-acetylmethadol and methadone in humans under acute dosing conditions.
The Journal of pharmacology and experimental therapeutics 1999;289(2):936-45.
1999: Eric C Strain; George E Bigelow; Ira A Liebson; Maxine L Stitzer
Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial.
JAMA : the journal of the American Medical Association 1999;281(11):1000-5.
1999: Mary Ann Chutuape; Kenneth Silverman; Maxine L Stitzer
Contingent reinforcement sustains post-detoxification abstinence from multiple drugs: a preliminary study with methadone patients.
Drug and alcohol dependence 1999;54(1):69-81.
1999: Elisabeth J Houtsmuller; Maxine L Stitzer
Manipulation of cigarette craving through rapid smoking: efficacy and effects on smoking behavior.
Psychopharmacology 1999;142(2):149-57.
1999: Maxine L Stitzer
Combined behavioral and pharmacological treatments for smoking cessation.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 1999;1 Suppl 2():S181-7; discussion S207-10.
1999: Mary Ann Chutuape; Kenneth Silverman; Maxine L Stitzer
Use of methadone take-home contingencies with persistent opiate and cocaine abusers.
Journal of substance abuse treatment 1999;16(1):23-30.
1998: Mark K Greenwald; Maxine L Stitzer
Butorphanol agonist effects and acute physical dependence in opioid abusers: comparison with morphine.
Drug and alcohol dependence 1998;53(1):17-30.
1998: Matthew J Carpenter; Mary Ann Chutuape; Maxine L Stitzer
Heroin snorters versus injectors: comparison on drug use and treatment outcome in age-matched samples.
Drug and alcohol dependence 1998;53(1):11-5.
1998: Hendrée E Jones; Eric C Strain; George E Bigelow; Sharon L Walsh; Maxine L Stitzer; Thomas Eissenberg; Rolley E. Johnson
Induction with levomethadyl acetate: safety and efficacy.
Archives of general psychiatry 1998;55(8):729-36.
1998: D W Wetter; M C Fiore; Ellen R Gritz; H A Lando; Maxine L Stitzer; V Hasselblad; Timothy B Baker
The Agency for Health Care Policy and Research Smoking Cessation Clinical Practice Guideline. Findings and implications for psychologists.
The American psychologist 1998;53(6):657-69.
1998: Elisabeth J Houtsmuller; Sharon L Walsh; Kory J Schuh; Rolley E. Johnson; Maxine L Stitzer; George E Bigelow
Dose-response analysis of opioid cross-tolerance and withdrawal suppression during LAAM maintenance.
The Journal of pharmacology and experimental therapeutics 1998;285(2):387-96.
1998: Mary Ann Chutuape; Kenneth Silverman; Maxine L Stitzer
Survey assessment of methadone treatment services as reinforcers.
The American journal of drug and alcohol abuse 1998;24(1):1-16.
1997: Dace S. Svikis; J H Lee; Nancy A Haug; Maxine L Stitzer
Attendance incentives for outpatient treatment: effects in methadone- and nonmethadone-maintained pregnant drug dependent women.
Drug and alcohol dependence 1997;48(1):33-41.
1997: STEPHEN HEISHMAN; K Arasteh; Maxine L Stitzer
Comparative effects of alcohol and marijuana on mood, memory, and performance.
Pharmacology, biochemistry, and behavior 1997;58(1):93-101.
1997: Maxine L Stitzer; Sharon L Walsh
Psychostimulant abuse: the case for combined behavioral and pharmacological treatments.
Pharmacology, biochemistry, and behavior 1997;57(3):457-70.
1997: Thomas Eissenberg; George E Bigelow; Eric C Strain; Sharon L Walsh; Robert K Brooner; Maxine L Stitzer; Rolley E. Johnson
Dose-related efficacy of levomethadyl acetate for treatment of opioid dependence. A randomized clinical trial.
JAMA : the journal of the American Medical Association 1997;277(24):1945-51.
1997: Mark K Greenwald; Maxine L Stitzer; K A Haberny
Human pharmacology of the opioid neuropeptide dynorphin A(1-13).
The Journal of pharmacology and experimental therapeutics 1997;281(3):1154-63.
1997: Mary Ann Chutuape; Robert K Brooner; Maxine L Stitzer
Sedative use disorders in opiate-dependent patients: association with psychiatric and other substance use disorders.
The Journal of nervous and mental disease 1997;185(5):289-97.
1997: J Gross; J Lee; Maxine L Stitzer
Nicotine-containing versus de-nicotinized cigarettes: effects on craving and withdrawal.
Pharmacology, biochemistry, and behavior 1997;57(1-2):159-65.
1997: Dace S. Svikis; Archie Golden; George Huggins; Roy W Pickens; Mary E McCaul; Martha Velez; C T Rosendale; Robert K Brooner; P M Gazaway; Maxine L Stitzer; C E Ball
Cost-effectiveness of treatment for drug-abusing pregnant women.
Drug and alcohol dependence 1997;45(1-2):105-13.
1997: Thomas Eissenberg; Rolley E. Johnson; George E Bigelow; Sharon L Walsh; Ira A Liebson; Eric C Strain; Maxine L Stitzer
Controlled opioid withdrawal evaluation during 72 h dose omission in buprenorphine-maintained patients.
Drug and alcohol dependence 1997;45(1-2):81-91.
1997: Kory J Schuh; Leslie M Schuh; Jack E Henningfield; Maxine L Stitzer
Nicotine nasal spray and vapor inhaler: abuse liability assessment.
Psychopharmacology 1997;130(4):352-61.
1997: Philip Clemmey; Robert K Brooner; Mary Ann Chutuape; Michael Kidorf; Maxine L Stitzer
Smoking habits and attitudes in a methadone maintenance treatment population.
Drug and alcohol dependence 1997;44(2-3):123-32.
1996: Thomas Eissenberg; Roland R Griffiths; Maxine L Stitzer
Mecamylamine does not precipitate withdrawal in cigarette smokers.
Psychopharmacology 1996;127(4):328-36.
1996: Michael Kidorf; Robert K Brooner; Van L King; Mary Ann Chutuape; Maxine L Stitzer
Concurrent validity of cocaine and sedative dependence diagnoses in opioid-dependent outpatients.
Drug and alcohol dependence 1996;42(2):117-23.
1996: Kory J Schuh; Sharon L Walsh; George E Bigelow; Kenzie L. Preston; Maxine L Stitzer
Buprenorphine, morphine and naloxone effects during ascending morphine maintenance in humans.
The Journal of pharmacology and experimental therapeutics 1996;278(2):836-46.
1996: Kenneth Silverman; Mary Ann Chutuape; George E Bigelow; Maxine L Stitzer
Voucher-based reinforcement of attendance by unemployed methadone patients in a job skills training program.
Drug and alcohol dependence 1996;41(3):197-207.
1996: Mark K Greenwald; Harry L June; Maxine L Stitzer; A P Marco
Comparative clinical pharmacology of short-acting mu opioids in drug abusers.
The Journal of pharmacology and experimental therapeutics 1996;277(3):1228-36.
1996: Eric C Strain; Maxine L Stitzer; Ira A Liebson; George E Bigelow
Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index.
Journal of clinical psychopharmacology 1996;16(1):58-67.
1996: Thomas Eissenberg; Mark K Greenwald; Rolley E. Johnson; Ira A Liebson; George E Bigelow; Maxine L Stitzer
Buprenorphine's physical dependence potential: antagonist-precipitated withdrawal in humans.
The Journal of pharmacology and experimental therapeutics 1996;276(2):449-59.
1995: Kenneth Silverman; Mary Ann Chutuape; Dace S. Svikis; George E Bigelow; Maxine L Stitzer
Incongruity between occupational interests and academic skills in drug abusing women.
Drug and alcohol dependence 1995;40(2):115-23.
1995: Rolley E. Johnson; Thomas Eissenberg; Maxine L Stitzer; Eric C Strain; Ira A Liebson; George E Bigelow
Buprenorphine treatment of opioid dependence: clinical trial of daily versus alternate-day dosing.
Drug and alcohol dependence 1995;40(1):27-35.
1995: Rolley E. Johnson; Thomas Eissenberg; Maxine L Stitzer; Eric C Strain; Ira A Liebson; George E Bigelow
A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence.
Drug and alcohol dependence 1995;40(1):17-25.
1995: Michael Kidorf; Maxine L Stitzer; Roland R Griffiths
Evaluating the reinforcement value of clinic-based privileges through a multiple choice procedure.
Drug and alcohol dependence 1995;39(3):167-72.
1995: Kory J Schuh; Maxine L Stitzer
Desire to smoke during spaced smoking intervals.
Psychopharmacology 1995;120(3):289-95.
1995: Sharon L Walsh; Kenzie L. Preston; George E Bigelow; Maxine L Stitzer
Acute administration of buprenorphine in humans: partial agonist and blockade effects.
The Journal of pharmacology and experimental therapeutics 1995;274(1):361-72.
1995: Sharon L Walsh; Harry L June; Kory J Schuh; Kenzie L. Preston; George E Bigelow; Maxine L Stitzer
Effects of buprenorphine and methadone in methadone-maintained subjects.
Psychopharmacology 1995;119(3):268-76.
1995: R V Fant; Kory J Schuh; Maxine L Stitzer
Response to smoking as a function of prior smoking amounts.
Psychopharmacology 1995;119(4):385-90.
1995: J Gross; J Johnson; L Sigler; Maxine L Stitzer
Dose effects of nicotine gum.
Addictive behaviors 1995;20(3):371-81.
1995: Harry L June; Maxine L Stitzer; Edward J Cone
Acute physical dependence: time course and relation to human plasma morphine concentrations.
Clinical pharmacology and therapeutics 1995;57(3):270-80.
1995: J L Azorlosa; Mark K Greenwald; Maxine L Stitzer
Marijuana smoking: effects of varying puff volume and breathhold duration.
The Journal of pharmacology and experimental therapeutics 1995;272(2):560-9.
1994: Michael Kidorf; Maxine L Stitzer; Robert K Brooner; J Goldberg
Contingent methadone take-home doses reinforce adjunct therapy attendance of methadone maintenance patients.
Drug and alcohol dependence 1994;36(3):221-6.
1994: Eric C Strain; Maxine L Stitzer; Ira A Liebson; George E Bigelow
Buprenorphine versus methadone in the treatment of opioid-dependent cocaine users.
Psychopharmacology 1994;116(4):401-6.
1994: Eric C Strain; Maxine L Stitzer; Ira A Liebson; George E Bigelow
Comparison of buprenorphine and methadone in the treatment of opioid dependence.
The American journal of psychiatry 1994;151(7):1025-30.
1994: Eric C Strain; Maxine L Stitzer; Ira A Liebson; George E Bigelow
Outcome after methadone treatment: influence of prior treatment factors and current treatment status.
Drug and alcohol dependence 1994;35(3):223-30.
1994: Sharon L Walsh; Kenzie L. Preston; Maxine L Stitzer; Edward J Cone; George E Bigelow
Clinical pharmacology of buprenorphine: ceiling effects at high doses.
Clinical pharmacology and therapeutics 1994;55(5):569-80.
1994: J Brigham; J Gross; Maxine L Stitzer; L J Felch
Effects of a restricted work-site smoking policy on employees who smoke.
American journal of public health 1994;84(5):773-8.
1994: J L Azolosa; Maxine L Stitzer; Mark K Greenwald
Opioid physical dependence development: effects of single versus repeated morphine pretreatments and of subjects' opioid exposure history.
Psychopharmacology 1994;114(1):71-80.
1993: Eric C Strain; Maxine L Stitzer; Ira A Liebson; George E Bigelow
Methadone dose and treatment outcome.
Drug and alcohol dependence 1993;33(2):105-17.
1993: Eric C Strain; Maxine L Stitzer; Ira A Liebson; George E Bigelow
Dose-response effects of methadone in the treatment of opioid dependence.
Annals of internal medicine 1993;119(1):23-7.
1993: Michael Kidorf; Maxine L Stitzer
Descriptive analysis of cocaine use of methadone patients.
Drug and alcohol dependence 1993;32(3):267-75.
1993: Maxine L Stitzer; M Y Iguchi; Michael Kidorf; George E Bigelow
Contingency management in methadone treatment: the case for positive incentives.
NIDA research monograph 1993;137():19-36.
1993: Kimberly Kirby; Maxine L Stitzer
Opioid physical dependence development in humans: effect of time between agonist pretreatments.
Psychopharmacology 1993;112(4):511-7.
1992: Maxine L Stitzer; M Y Iguchi; L J Felch
Contingent take-home incentive: effects on drug use of methadone maintenance patients.
Journal of consulting and clinical psychology 1992;60(6):927-34.
1992: Maxine L Stitzer; J Brigham; L J Felch
Phase-out filter perforation: effects on human tobacco smoke exposure.
Pharmacology, biochemistry, and behavior 1992;41(4):749-54.
1992: J L Azorlosa; STEPHEN HEISHMAN; Maxine L Stitzer; J M Mahaffey
Marijuana smoking: effect of varying delta 9-tetrahydrocannabinol content and number of puffs.
The Journal of pharmacology and experimental therapeutics 1992;261(1):114-22.
1992: W M Chornock; Maxine L Stitzer; J Gross; S Leischow
Experimental model of smoking re-exposure: effects on relapse.
Psychopharmacology 1992;108(4):495-500.
1992: Jack E Henningfield; E Obarzanek; N L Benowitz; S M Hall; R C Klesges; S Leischow; Edward Levin; K A Perkins; Bonnie Spring; Maxine L Stitzer
National working conference on smoking and body weight. Task Force 2: Methods of assessment, strategies for research.
Health psychology : official journal of the Division of Health Psychology, American Psychological Association 1992;11 Suppl():10-6.
1991: Maxine L Stitzer; C Wright; George E Bigelow; Harry L June; L J Felch
Time course of naloxone-precipitated withdrawal after acute methadone exposure in humans.
Drug and alcohol dependence 1991;29(1):39-46.
1991: M Y Iguchi; Maxine L Stitzer
Predictors of opiate drug abuse during a 90-day methadone detoxification.
The American journal of drug and alcohol abuse 1991;17(3):279-94.
1991: S J Leischow; Maxine L Stitzer
Smoking cessation and weight gain.
British journal of addiction 1991;86(5):577-81.
1991: Eric C Strain; Maxine L Stitzer; George E Bigelow
Early treatment time course of depressive symptoms in opiate addicts.
The Journal of nervous and mental disease 1991;179(4):215-21.
1991: C Wright; George E Bigelow; Maxine L Stitzer; Ira A Liebson
Acute physical dependence in humans: repeated naloxone-precipitated withdrawal after a single dose of methadone.
Drug and alcohol dependence 1991;27(2):139-48.
1991: Maxine L Stitzer; Kimberly Kirby
Reducing illicit drug use among methadone patients.
NIDA research monograph 1991;106():178-203.
1991: S J Leischow; Maxine L Stitzer
Effects of smoking cessation on caloric intake and weight gain in an inpatient unit.
Psychopharmacology 1991;104(4):522-6.
1990: Kimberly Kirby; Maxine L Stitzer; STEPHEN HEISHMAN
Acute opioid physical dependence in humans: effect of varying the morphine-naloxone interval II.
The Journal of pharmacology and experimental therapeutics 1990;255(2):730-7.
1990: J Brigham; Jack E Henningfield; Maxine L Stitzer
Smoking relapse: a review.
The International journal of the addictions 1990;25(9A-10A):1239-55.
1990: STEPHEN HEISHMAN; Maxine L Stitzer; George E Bigelow; Ira A Liebson
Acute opioid physical dependence in humans: effect of naloxone at 6 and 24 hours postmorphine.
Pharmacology, biochemistry, and behavior 1990;36(2):393-9.
1990: J J Boren; Maxine L Stitzer; Jack E Henningfield
Preference among research cigarettes with varying nicotine yields.
Pharmacology, biochemistry, and behavior 1990;36(1):191-3.
1990: Marilyn Carroll; Maxine L Stitzer; Eric C Strain; R A Meisch
The behavioral pharmacology of alcohol and other drugs. Emerging issues.
Recent developments in alcoholism : an official publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism 1990;8():5-46.
1990: J L Azorlosa; Maxine L Stitzer
Acute physical dependence in opiate-naive humans.
NIDA research monograph 1990;105():451.
1990: Kimberly Kirby; Maxine L Stitzer
Acute opioid physical dependence in humans: effects of varying the morphine-morphine interval.
NIDA research monograph 1990;105():449-50.
1989: Stephen T Higgins; Maxine L Stitzer
Monologue speech: effects of d-amphetamine, secobarbital and diazepam.
Pharmacology, biochemistry, and behavior 1989;34(3):609-18.
1989: Mary E McCaul; J S Turkkan; Maxine L Stitzer
Conditioned opponent responses: effects of placebo challenge in alcoholic subjects.
Alcoholism, clinical and experimental research 1989;13(5):631-5.
1989: STEPHEN HEISHMAN; Maxine L Stitzer; J E Yingling
Effects of tetrahydrocannabinol content on marijuana smoking behavior, subjective reports, and performance.
Pharmacology, biochemistry, and behavior 1989;34(1):173-9.
1989: STEPHEN HEISHMAN; Maxine L Stitzer; George E Bigelow; Ira A Liebson
Acute opioid physical dependence in humans: effect of varying the morphine-naloxone interval. I.
The Journal of pharmacology and experimental therapeutics 1989;250(2):485-91.
1989: L L Weinhold; Maxine L Stitzer
Effects of puff number and puff spacing on carbon monoxide exposure from commercial brand cigarettes.
Pharmacology, biochemistry, and behavior 1989;33(4):853-8.
1989: J S Turkkan; Mary E McCaul; Maxine L Stitzer
Psychophysiological effects of alcohol-related stimuli: II. Enhancement with alcohol availability.
Alcoholism, clinical and experimental research 1989;13(3):392-8.
1989: Mary E McCaul; J S Turkkan; Maxine L Stitzer
Psychophysiological effects of alcohol-related stimuli: I. The role of stimulus intensity.
Alcoholism, clinical and experimental research 1989;13(3):386-91.
1989: J Gross; Maxine L Stitzer; J Maldonado
Nicotine replacement: effects of postcessation weight gain.
Journal of consulting and clinical psychology 1989;57(1):87-92.
1989: STEPHEN HEISHMAN; Maxine L Stitzer; George E Bigelow; Ira A Liebson
Acute opioid physical dependence in postaddict humans: naloxone dose effects after brief morphine exposure.
The Journal of pharmacology and experimental therapeutics 1989;248(1):127-34.
1989: Cynthia S Rand; Maxine L Stitzer; George E Bigelow; A M Mead
The effects of contingent payment and frequent workplace monitoring on smoking abstinence.
Addictive behaviors 1989;14(2):121-8.
1989: C Wright; George E Bigelow; Maxine L Stitzer
Acute physical dependence in man: repeated naloxone-precipitated withdrawal after a single dose of methadone.
NIDA research monograph 1989;95():395-6.
1989: Kimberly Kirby; Maxine L Stitzer; STEPHEN HEISHMAN
Acute opioid physical dependence in humans: maximum morphine-naloxone interval.
NIDA research monograph 1989;95():393-4.
1989: STEPHEN HEISHMAN; Maxine L Stitzer
Time course of repeated naloxone challenge after single morphine doses in humans.
NIDA research monograph 1989;95():385-6.
1989: STEPHEN HEISHMAN; Maxine L Stitzer
Effect of d-amphetamine, secobarbital, and marijuana on choice behavior: social versus nonsocial options.
Psychopharmacology 1989;99(2):156-62.
1989: J Gross; Maxine L Stitzer
Nicotine replacement: ten-week effects on tobacco withdrawal symptoms.
Psychopharmacology 1989;98(3):334-41.
1988: STEPHEN HEISHMAN; Maxine L Stitzer; George E Bigelow
Alcohol and marijuana: comparative dose effect profiles in humans.
Pharmacology, biochemistry, and behavior 1988;31(3):649-55.
1988: M Y Iguchi; Maxine L Stitzer; George E Bigelow; Ira A Liebson
Contingency management in methadone maintenance: effects of reinforcing and aversive consequences on illicit polydrug use.
Drug and alcohol dependence 1988;22(1-2):1-7.
1988: W K Bickel; Maxine L Stitzer; George E Bigelow; Ira A Liebson; Donald R Jasinski; Rolley E. Johnson
Buprenorphine: dose-related blockade of opioid challenge effects in opioid dependent humans.
The Journal of pharmacology and experimental therapeutics 1988;247(1):47-53.
1988: L L Weinhold; Maxine L Stitzer; J E Yingling
Carbon monoxide exposure from commercial brand cigarettes under controlled smoking conditions.
Pharmacology, biochemistry, and behavior 1988;31(1):93-6.
1988: Stephen T Higgins; Maxine L Stitzer
Time allocation in a concurrent schedule of social interaction and monetary reinforcement: effects of d-amphetamine.
Pharmacology, biochemistry, and behavior 1988;31(1):227-31.
1988: J P Zacny; Maxine L Stitzer
Cigarette brand-switching: effects on smoke exposure and smoking behavior.
The Journal of pharmacology and experimental therapeutics 1988;246(2):619-27.
1988: J S Turkkan; Maxine L Stitzer; Mary E McCaul
Psychophysiological effects of oral ethanol in alcoholics and social drinkers.
Alcoholism, clinical and experimental research 1988;12(1):30-8.
1988: Warren K Bickel; Maxine L Stitzer; I A Liebson; George E Bigelow
Acute physical dependence in man: effects of naloxone after brief morphine exposure.
The Journal of pharmacology and experimental therapeutics 1988;244(1):126-32.
1988: Maxine L Stitzer; J Gross
Smoking relapse: the role of pharmacological and behavioral factors.
Progress in clinical and biological research 1988;261():163-84.
1988: W K Bickel; Maxine L Stitzer; George E Bigelow; Ira A Liebson; Donald R Jasinski; Rolley E. Johnson
A clinical trial of buprenorphine: comparison with methadone in the detoxification of heroin addicts.
Clinical pharmacology and therapeutics 1988;43(1):72-8.
1988: Stephen T Higgins; Maxine L Stitzer
Effects of alcohol on speaking in isolated humans.
Psychopharmacology 1988;95(2):189-94.
1988: Maxine L Stitzer; J Gross
Nicotine replacement effects on post-cessation withdrawal symptoms and weight gain.
NIDA research monograph 1988;81():53-8.
1988: Mary E McCaul; J Turkkan; Maxine L Stitzer
Placebo challenge: effects following repeated alcohol vs. placebo administration.
NIDA research monograph 1988;81():40-6.
1988: STEPHEN HEISHMAN; Maxine L Stitzer
Acute opioid physical dependence in humans: naloxone dose response effects.
NIDA research monograph 1988;81():195-201.
1987: J P Zacny; Maxine L Stitzer; F J Brown; J E Yingling; Roland R Griffiths
Human cigarette smoking: effects of puff and inhalation parameters on smoke exposure.
The Journal of pharmacology and experimental therapeutics 1987;240(2):554-64.
1987: Maxine L Stitzer; W K Bickel; George E Bigelow
Altered dose incentive procedures: effects on polydrug use among methadone maintenance patients.
NIDA research monograph 1987;76():162-7.
1987: Mary E McCaul; J S Turkkan; Maxine L Stitzer
Psychophysiological effects of alcohol-related stimuli.
NIDA research monograph 1987;76():131-6.
1987: W K Bickel; Rolley E. Johnson; Maxine L Stitzer; George E Bigelow; Ira A Liebson; Donald R Jasinski
A clinical trial of buprenorphine: I. Comparison with methadone in the detoxification of heroin addicts. II. Examination of its opioid blocking properties.
NIDA research monograph 1987;76():182-8.
1986: Maxine L Stitzer; W K Bickel; George E Bigelow; I A Liebson
Effect of methadone dose contingencies on urinalysis test results of polydrug-abusing methadone-maintenance patients.
Drug and alcohol dependence 1986;18(4):341-8.
1986: J P Zacny; Maxine L Stitzer; J E Yingling
Cigarette filter vent blocking: effects on smoking topography and carbon monoxide exposure.
Pharmacology, biochemistry, and behavior 1986;25(6):1245-52.
1986: W K Bickel; S T Higgins; Maxine L Stitzer
Choice of blind methadone dose increases by methadone maintenance patients.
Drug and alcohol dependence 1986;18(2):165-71.
1986: S T Higgins; Maxine L Stitzer; George E Bigelow; I A Liebson
Contingent methadone delivery: effects on illicit-opiate use.
Drug and alcohol dependence 1986;17(4):311-22.
1986: Maxine L Stitzer; Cynthia S Rand; George E Bigelow; A M Mead
Contingent payment procedures for smoking reduction and cessation.
Journal of applied behavior analysis 1986;19(2):197-202.
1986: J P Zacny; Maxine L Stitzer
Effect of puff size instructions on puff volume.
Addictive behaviors 1986;11(1):17-23.
1986: W K Bickel; Maxine L Stitzer; B E Wazlavek; I A Liebson
Naloxone-precipitated withdrawal in humans after acute morphine administration.
NIDA research monograph 1986;67():349-54.
1986: S T Higgins; Maxine L Stitzer
Acute marijuana effects on social conversation.
Psychopharmacology 1986;89(2):234-8.
1985: J P Zacny; Maxine L Stitzer
Effects of smoke deprivation interval on puff topography.
Clinical pharmacology and therapeutics 1985;38(1):109-15.
1985: S T Higgins; Maxine L Stitzer; Mary E McCaul; George E Bigelow; I A Liebson
Pupillary response to methadone challenge in heroin users.
Clinical pharmacology and therapeutics 1985;37(4):460-3.
1985: Maxine L Stitzer; George E Bigelow
Contingent reinforcement for reduced breath carbon monoxide levels: target-specific effects on cigarette smoking.
Addictive behaviors 1985;10(4):345-9.
1985: T A Burling; Maxine L Stitzer; George E Bigelow; A M Mead
Smoking topography and carbon monoxide levels in smokers.
Addictive behaviors 1985;10(3):319-23.
1985: Maxine L Stitzer; George E Bigelow; Mary E McCaul
Behavior therapy in drug abuse treatment: review and evaluation.
NIDA research monograph 1985;58():31-50.
1984: Kenzie L. Preston; Roland R Griffiths; Maxine L Stitzer; George E Bigelow; I A Liebson
Diazepam and methadone interactions in methadone maintenance.
Clinical pharmacology and therapeutics 1984;36(4):534-41.
1984: Maxine L Stitzer; Mary E McCaul; George E Bigelow; I A Liebson
Chronic opiate use during methadone detoxification: effects of a dose increase treatment.
Drug and alcohol dependence 1984;14(1):37-44.
1984: Maxine L Stitzer; George E Bigelow; I A Liebson
Single-day methadone dose alteration: detectability and symptoms.
Clinical pharmacology and therapeutics 1984;36(2):244-50.
1984: Maxine L Stitzer; George E Bigelow
Contingent methadone take-home privileges: effects on compliance with fee payment schedules.
Drug and alcohol dependence 1984;13(4):395-9.
1984: Maxine L Stitzer
Verbal responding under a fixed-interval schedule: effects of D-amphetamine.
Pharmacology, biochemistry, and behavior 1984;21(1):67-72.
1984: Mary E McCaul; Maxine L Stitzer; George E Bigelow; I A Liebson
Methadone detoxification: effects of methadone dose versus time in treatment.
NIDA research monograph 1984;49():269-74.
1984: Maxine L Stitzer; Mary E McCaul; George E Bigelow; I A Liebson
Comparison of a behavioral and a pharmacological treatment for reduction of illicit opiate use.
NIDA research monograph 1984;49():255-61.
1984: Mary E McCaul; Maxine L Stitzer; George E Bigelow; I A Liebson
Contingency management interventions: effects on treatment outcome during methadone detoxification.
Journal of applied behavior analysis 1984;17(1):35-43.
1984: Maxine L Stitzer; George E Bigelow
Contingent reinforcement for carbon monoxide reduction: within-subject effects of pay amount.
Journal of applied behavior analysis 1984;17(4):477-83.
1984: Maxine L Stitzer; Mary E McCaul; George E Bigelow; I A Liebson
Effects of a dose increase on chronic opiate use during methadone detoxification.
NIDA research monograph 1984;55():197-201.
1984: Mary E McCaul; Maxine L Stitzer; George E Bigelow; I A Liebson
Outpatient methadone detoxification: effects of diazepam and doxepin as adjunct medications.
NIDA research monograph 1984;55():191-6.
1984: S T Higgins; Maxine L Stitzer; George E Bigelow; I A Liebson
Contingent methadone dose increases as a method for reducing illicit opiate use in detoxification patients.
NIDA research monograph 1984;55():178-84.
1984: George E Bigelow; Maxine L Stitzer; I A Liebson
The role of behavioral contingency management in drug abuse treatment.
NIDA research monograph 1984;46():36-52.
1984: Maxine L Stitzer; J Grabowski; Jack E Henningfield
Behavioral intervention techniques in drug abuse treatment: summary of discussion.
NIDA research monograph 1984;46():147-57.
1984: J Grabowski; Maxine L Stitzer; Jack E Henningfield
Therapeutic application of behavioral techniques: an overview.
NIDA research monograph 1984;46():1-7.
1984: George E Bigelow; Joseph V. Brady; Roland R Griffiths; Maxine L Stitzer; Nancy A Ator; S T Higgins; I A Liebson; S E Lucas
Progress report from the Division of Behavioral Biology, the Johns Hopkins University School of Medicine.
NIDA research monograph 1984;55():66-75.
1984: Maxine L Stitzer; George E Bigelow; I A Liebson; Mary E McCaul
Contingency management of supplemental drug use during methadone maintenance treatment.
NIDA research monograph 1984;46():84-103.
1984: Kenzie L. Preston; George E Bigelow; Maxine L Stitzer; I A Liebson
Three-choice discrimination in methadone maintenance patients: hydromorphone, naloxone, and saline.
NIDA research monograph 1984;55():151-7.
1984: Maxine L Stitzer; Mary E McCaul; G E Bigleow; I A Liebson
Hydromorphone effects on human conversational speech.
Psychopharmacology 1984;84(3):402-4.
1983: Maxine L Stitzer; Mary E McCaul; George E Bigelow; I Liebson
Treatment outcome in methadone detoxification: relationship to initial levels of illicit opiate use.
Drug and alcohol dependence 1983;12(3):259-67.
1983: Maxine L Stitzer; Mary E McCaul; George E Bigelow; I A Liebson
Oral methadone self-administration: effects of dose and alternative reinforcers.
Clinical pharmacology and therapeutics 1983;34(1):29-35.
1983: Mary E McCaul; Maxine L Stitzer; George E Bigelow; I A Liebson
Initial opiate use and treatment outcome in methadone detoxification patients.
NIDA research monograph 1983;43():280-6.
1983: George E Bigelow; Roland R Griffiths; Maxine L Stitzer; I A Liebson
Development of clinical procedures for abuse liability assessment: progress report from the Behavioral Pharmacology Research Unit of the Johns Hopkins University School of Medicine and Baltimore City Hospitals.
NIDA research monograph 1983;43():125-31.
1983: Mary E McCaul; Maxine L Stitzer; George E Bigelow; I A Liebson
Intravenous hydromorphone: effects in opiate-free and methadone maintenance subjects.
NIDA research monograph 1983;43():238-44.
1982: Mary E McCaul; George E Bigelow; Maxine L Stitzer; I Liebson
Short-term effects of oral methadone in methadone maintenance subjects.
Clinical pharmacology and therapeutics 1982;31(6):753-61.
1982: Maxine L Stitzer; George E Bigelow; I Liebson
Contingent reinforcement of benzodiazepine-free urines from methadone maintenance patients.
NIDA research monograph 1982;41():282-7.
1982: Maxine L Stitzer; George E Bigelow; I A Liebson
Comparison of three outpatient methadone detoxification procedures.
NIDA research monograph 1982;41():239-45.
1982: Mary E McCaul; Maxine L Stitzer; George E Bigelow; I Liebson
Physiological and subjective effects of hydromorphone in postaddict volunteers.
NIDA research monograph 1982;41():301-8.
1982: Maxine L Stitzer; George E Bigelow
Contingent reinforcement for reduced carbon monoxide levels in cigarette smokers.
Addictive behaviors 1982;7(4):403-12.
1982: T A Burling; Maxine L Stitzer; George E Bigelow; N W Russ
Techniques used by smokers during contingency motivated smoking reduction.
Addictive behaviors 1982;7(4):397-401.
1982: W F Baile; George E Bigelow; Sheldon H Gottlieb; Maxine L Stitzer; J D Sacktor
Rapid resumption of cigarette smoking following myocardial infarction: inverse relation to MI severity.
Addictive behaviors 1982;7(4):373-80.
1982: Maxine L Stitzer; George E Bigelow; I A Liebson; J W Hawthorne
Contingent reinforcement for benzodiazepine-free urines: evaluation of a drug abuse treatment intervention.
Journal of applied behavior analysis 1982;15(4):493-503.
1981: Maxine L Stitzer; Roland R Griffiths; A T McLellan; J Grabowski; J W Hawthorne
Diazepam use among methadone maintenance patients: patterns and dosages.
Drug and alcohol dependence 1981;8(3):189-99.
1981: Maxine L Stitzer; Roland R Griffiths; George E Bigelow; I A Liebson
Social stimulus factors in drug effects in human subjects.
NIDA research monograph 1981;37():130-54.
1981: Maxine L Stitzer; Roland R Griffiths; George E Bigelow; I Liebson
Human social conversation: effects of ethanol, secobarbital and chlorpromazine.
Pharmacology, biochemistry, and behavior 1981;14(3):353-60.
1981: Maxine L Stitzer; G E Bieglow; I Liebson
Granting dose increases to methadone maintenance patients: effects on symptomatology and drug use.
NIDA research monograph 1981;34():387-93.
1981: George E Bigelow; Maxine L Stitzer; Roland R Griffiths; I A Liebson
Contingency management approaches to drug self-administration and drug abuse: efficacy and limitations.
Addictive behaviors 1981;6(3):241-52.
1980: George E Bigelow; Maxine L Stitzer; C Lawrence; N Krasnegor; BURTON D'LUGOFF; J Hawthorne
Narcotics addiction treatment: behavioral methods concurrent with methadone maintenance.
The International journal of the addictions 1980;15(3):427-37.
1980: Jack E Henningfield; Maxine L Stitzer; Roland R Griffiths
Expired air carbon monoxide accumulation and elimination as a function of number of cigarettes smoked.
Addictive behaviors 1980;5(3):265-72.
1980: Maxine L Stitzer; George E Bigelow; I Liebson
Reducing drug use among methadone maintenance clients: contingent reinforcement for morphine-free urines.
Addictive behaviors 1980;5(4):333-40.
1979: Maxine L Stitzer; George E Bigelow; I Liebson
Reinforcement of drug abstinence: a behavioral approach to drug abuse treatment.
NIDA research monograph 1979;(25):68-90.
1979: Maxine L Stitzer; George E Bigelow; I Liebson
Reducing benzodiazepine self-administration with contingent reinforcement.
Addictive behaviors 1979;4(3):245-52.
1979: Maxine L Stitzer; George E Bigelow; I Liebson
Supplementary methadone self administration among methadone maintenance clients.
Addictive behaviors 1979;4(1):61-6.
1978: Maxine L Stitzer; George E Bigelow
Contingency management in a methadone maintenance program: availability of reinforcers.
The International journal of the addictions 1978;13(5):737-46.
1978: Maxine L Stitzer; Roland R Griffiths; I Liebson
Effects of d-amphetamine on speaking in isolated humans.
Pharmacology, biochemistry, and behavior 1978;9(1):57-63.
1978: Maxine L Stitzer; George E Bigelow
Drug abuse research in outpatient clinics.
NIDA research monograph 1978;(20):59-67.
1977: Roland R Griffiths; Maxine L Stitzer; K Corker; George E Bigelow; I Liebson
Drug-produced changes in human social behavior: facilitation by d-amphetamine.
Pharmacology, biochemistry, and behavior 1977;7(4):365-72.
1977: Maxine L Stitzer
Drug impairment reviews: other drugs.
NIDA research monograph 1977;Series 11():113-24.
1977: Maxine L Stitzer; George E Bigelow; C Lawrence; J Cohen; BURTON D'LUGOFF; J Hawthorne
Medication take-home as a reinforcer in a methadone maintenance program.
Addictive behaviors 1977;2(1):9-14.
1977: Maxine L Stitzer; J W McKearney
Drug effects on fixed-interval responding with pause requirements for food presentation.
Journal of the experimental analysis of behavior 1977;27(1):51-9.
1975: Gail Winger; Maxine L Stitzer; James H Woods
Barbiturate-reinforced responding in rhesus monkeys: comparisons of drugs with different durations of action.
The Journal of pharmacology and experimental therapeutics 1975;195(3):505-14.
1974: Maxine L Stitzer
Comparison of morphine and chlorpromazine effects on moderately and severely suppressed punished responding in the pigeon.
The Journal of pharmacology and experimental therapeutics 1974;191(1):172-8.
1974: Maxine L Stitzer; Edward Domino
Effects of d-amphetamine and secobarbital on key press rates in normal humans.
Archives internationales de pharmacodynamie et de thérapie 1974;207(2):288-97.
1970: Maxine L Stitzer; J Morrison; Edward Domino
Effects of nicotine on fixed-interval behavior and their modification by cholinergic antagonists.
The Journal of pharmacology and experimental therapeutics 1970;171(2):166-77.